Latest Articles

Professor Donald Ingber is responsible for developing human organ chips, which provide researchers with a window into inter-organ physiology and the body’s response to drugs, without animal testing. Technology Networks' invited Ingber to an Ask Me Anything session to answer your questions about this incredible technology.

In this article, we explore ways analytical scientists can improve their data reporting and sharing practices, leading to improvements in data integrity and regulatory compliance.

Join us as we sit down with Professor Emma Lundberg, a luminary in the field of spatial biology, to discuss her incredible career journey, the challenges that she has overcome and the groundbreaking discoveries that continue to shape the future of science and medicine.

From RNAi to CRISPR, there are several methods that researchers can use to manipulate gene function. This article explores how orthogonal validation – the synergistic use of different methods – makes genetic perturbation studies more robust.

Explore the current state of decentralization in cell therapy manufacturing as well as the challenges and future technologies that may define the space.

Capillary electrophoresis is a powerful separation and analysis technique that offers quick and efficient results. In this article, we explore how it works, variations on the technique and their applications.

By decoding the biological lexicon and integrating diverse forms of data, AI offers new possibilities for modeling biology and designing therapies. In this article, we explore the potential of recent advancements in AI to revolutionize drug R&D.

A recent study found that over one-third of men aged 15 years and over are infected with at least one type of HPV. In this article, we explore why HPV is not just a women's health issue.

Scientists have found a way to reverse infertility in a sterile mouse model by reducing the concentration of plasma high-density lipoproteins, known to impact fertility, using constitutively expressed bacterial serum opacity factor.

In this article, we consider various platforms to modulate gene expression and the potential of CRISPR-Cas systems to understand and treat diseases, from cancers and congenital disorders to overcoming the growing prevalence of antimicrobial resistance.